Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Current evidence for prognostic benefit of intravascular imaging-guided percutaneous coronary intervention in chronic total occlusion intervention
Korean J Intern Med. 2024 Feb 29. doi: 10.3904/kjim.2023.420. Online ahead of print.ABSTRACTAlthough percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has been increasing in recent years, CTO PCI is still one of the most challenging procedures with relatively higher rates of procedural complications and adverse clinical events after PCI. Due to the innate limitations of invasive coronary angiography, intravascular imaging (IVI) has been used as an adjunctive tool to complement PCI, especially in complex coronary artery disease. Considering the complexity of CTO lesions, the role of IVI is particula...
Source: The Korean Journal of Internal Medicine - February 29, 2024 Category: Internal Medicine Authors: David Hong Sung Eun Kim Seung Hun Lee Seung-Jae Lee Jong-Young Lee Sang Min Kim Sang Yeub Lee Woochan Kwon Ki Hong Choi Taek Kyu Park Jeong Hoon Yang Young Bin Song Seung-Hyuk Choi Hyeon-Cheol Gwon Joo-Yong Hahn Joo Myung Lee RENOVATE-COMPLEX-PCI Investig Source Type: research

Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency
CONCLUSIONS: The findings suggest that SES plays a significant role in biologics use among RA patients, indicating potential healthcare inefficiencies for low SES patients. Moreover, adverse healthcare habits negatively affect biologics use in RA patients. The study highlights the importance of considering socioeconomic factors while discussing biologics use and promoting equitable access to biologics for optimal RA management.PMID:38419335 | DOI:10.3904/kjim.2023.276 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - February 29, 2024 Category: Internal Medicine Authors: Hye Won Kim Yeon Ju Lee You-Jung Ha Eun Bong Lee Yun Jong Lee Eun Ha Kang Source Type: research

Current evidence for prognostic benefit of intravascular imaging-guided percutaneous coronary intervention in chronic total occlusion intervention
Korean J Intern Med. 2024 Feb 29. doi: 10.3904/kjim.2023.420. Online ahead of print.ABSTRACTAlthough percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has been increasing in recent years, CTO PCI is still one of the most challenging procedures with relatively higher rates of procedural complications and adverse clinical events after PCI. Due to the innate limitations of invasive coronary angiography, intravascular imaging (IVI) has been used as an adjunctive tool to complement PCI, especially in complex coronary artery disease. Considering the complexity of CTO lesions, the role of IVI is particula...
Source: The Korean Journal of Internal Medicine - February 29, 2024 Category: Internal Medicine Authors: David Hong Sung Eun Kim Seung Hun Lee Seung-Jae Lee Jong-Young Lee Sang Min Kim Sang Yeub Lee Woochan Kwon Ki Hong Choi Taek Kyu Park Jeong Hoon Yang Young Bin Song Seung-Hyuk Choi Hyeon-Cheol Gwon Joo-Yong Hahn Joo Myung Lee RENOVATE-COMPLEX-PCI Investig Source Type: research